VBIV - vbivaccines.com Operating income before deduction of amortization

Graphic logo of VBI Vaccines, Inc. (VBIV)

VBI Vaccines Inc. (VBIV) maintains its resilience based on patent protection of VLP technologies for combating brain cancer and hepatitis B. The sale of approved drugs across various countries ensures a stable income stream. EBITDA cash flow reflects daily operational results, where the value of indicates the current magnitude. Its status as a technological leader is confirmed by a powerful R&D potential in the development of innovative eVLP-based antiviral vaccines.

VBIV - VBI Vaccines, Inc. Operating profit before deduction of amortization over the range 07/04/2022 - 11/16/2026

VBI Vaccines Inc - analytical breakdowns and key metrics (VBIV)

- stock price and consensus target price:
Summary company analytics:vbivaccines.com (VBIV)
Signature product of VBI Vaccines, Inc.

The flexible production model of VBI Vaccines Inc. (VBIV), which combines its own facility in Canada with European CMO capacities, directly impacts operational efficiency. By analyzing EBITDA volatility, the investor assesses earnings before interest, taxes, depreciation, and amortization, which determines the business's actual ability to generate cash flow and confirms the asset's financial stability.

Who VBI Vaccines Inc. competes with

Gilead Sciences, Inc. - Profit before payment of interest, taxes and amortization|Cidara Therapeutics Corp - Operating profit EBITDA|Operating income before deduction of amortization Novavax Inc NVAX|CureVac Corp (CVAC) - Profit before payment of interest, taxes and amortization|Valneva SE - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization vir.bio|Operating profit EBITDA siga.com|Operating profit EBITDA EBS|Operating income before deduction of amortization Atea Pharmaceuticals, Inc.|Operating profit EBITDA IVVD (invivyd.com)|Enanta Pharmaceuticals, Inc (ENTA) - Profit before interest, taxes and amortization|INO - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization hillevax.com HLVX|Kalaris Therapeutics (KLRS) - Profit before payment of interest, taxes and amortization|Dyadic International Inc (DYAI) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization NanoViricides Inc.|Talphera Corp - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit before deduction of amortization COCP (Cocrystal Pharma Inc)|Operating income before deduction of amortization Traws Therapeutics|Profit before payment of interest, taxes and amortization Dogwood Therapeutics DWTX|Operating profit before depreciation charges Qualigen Therapeutics, Inc.|ALVR - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization VIRI (Virios Therapeutics Inc.)|VXRT: Operating profit EBITDA